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Abstract: Ochratoxin A (OTA) is a powerful mycotoxin found in various foods and feedstuff, respon-
sible for subchronic and chronic toxicity, such as nephrotoxicity, hepatotoxicity, teratogenicity, and
immunotoxicity to both humans and several animal species. The severity of the liver damage caused
depends on both dose and duration of exposure. Several studies have suggested that oxidative
stress might contribute to increasing the hepatotoxicity of OTA, and several antioxidants, including
curcumin (CURC), have been tested to counteract the toxic hepatic action of OTA in various classes
of animals. Therefore, the present study was designed to evaluate the protective effect of CURC, a
bioactive compound with different therapeutic properties on hepatic injuries caused by OTA in rat an-
imal models. CURC effects were examined in Sprague Dawley rats treated with CURC (100 mg/kg),
alone or in combination with OTA (0.5 mg/kg), by gavage daily for 14 days. At the end of the
experiment, rats treated with OTA showed alterations in biochemical parameters and oxidative stress
in the liver. CURC dosing significantly attenuated oxidative stress and lipid peroxidation versus
the OTA group. Furthermore, liver histological tests showed that CURC reduced the multifocal
lymphoplasmacellular hepatitis, the periportal fibrosis, and the necrosis observed in the OTA group.
This study provides evidence that CURC can preserve OTA-induced oxidative damage in the liver
of rats.
Keywords: ochratoxin A; curcumin; oxidative stress; liver; toxicity
1. Introduction
Oxidative stress has become a new hot spot in the context of mycotoxin mechanism
of action [1]. In fact, oxidative stress is hypothesized to be one of the main causes in the
development of many disorders such as chronic kidney disease, hepatic inflammation,
hypercholesterolemia, diabetes, and hepatic cirrhosis [2]. Oxidative stress involves an
excessive production of free radicals, which, in turn, induce oxidative damage to cellu-
lar biomolecules, including proteins, lipids, and nucleic acids, in numerous tissues [3].
Several studies indicate that oxidative stress plays critical roles in the toxicity of ochra-
toxin A (OTA) [4,5]. To date, more than 300 mycotoxins have been identified; however,
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due to their toxic levels and contamination profiles, several groups are particularly inter-
esting, including aflatoxins, OTA, trichothecenes (including T-2 toxin, deoxynivalenol),
fumonisins, zearalenone, and patulin [6,7]. OTA, a mycotoxin produced by Aspergillus and
Penicillium genera, is one of the most detected mycotoxins in food and foodstuffs such
as coffee beans, fermented tea, and cereals [8]. This toxin inflicts losses to farmers and
reduces the value of contaminated feeds. Effects in animals subjected to the ingestion of
these fungal compounds vary from acute, overt disease with high morbidity and death to
chronic, decreased resistance to pathogens and reduced animal productivity [9,10]. The
major clinical complication associated with animal feed contaminated with mycotoxins is
not acute disease, but rather chronic disease, caused by the ingestion of small quantities of
poisoned food which may lead to an array of metabolic, physiologic, and immunologic
disorders [9,10]. OTA often causes chronic toxicity, due to the prolonged intake of its
small amounts, and manifests itself with hepatotoxic, carcinogenic, genotoxic, teratogenic,
nephrotoxic, and immunosuppressive effects, affecting both humans and numerous an-
imal species [11,12]. Among the animal productions, the risk is limited to monogastric
species since the OTA amide bond can be hydrolyzed by ruminants and form a nontoxic
molecule [13]. Pigs are the most susceptible to the accumulation of OTA, whose tissue
deposition occurs as follows: kidney > liver > muscle > fat [14]. In addition, OTA was
classified by the International Agency for Research on Cancer (IARC) in group 2B, as
possibly carcinogenic to humans, based on the kidney and liver tumors reported in mice
and rats [15]. The main organ subjected to toxicological studies is the liver, since this organ
has a special role in the metabolism, storage, redistribution, and excretion of endogenous
and exogenous substances in the body [16]. Even if OTA effects are known, the molecu-
lar mechanisms underlying the damage are still not completely clarified. OTA exposure
(in vitro or in vivo) has been related to overproduction of reactive oxygen species (ROS),
as well as oxidative damage (lipids, proteins, and DNA). In addition, OTA may reduce
the antioxidant defense of cells by reducing GSH and cytoprotective enzymes [17]. It has
been demonstrated that antioxidants could protect cells against OTA-induced cytotoxicity
and genotoxicity [18,19]. The use of bioactive compounds has emerged as a potential
approach to reduce toxicity induced by environmental contaminants such as mycotoxicosis.
Curcumin (CURC), a polyphenolic compound, is a natural bioactive constituent isolated
from the rhizome of Curcuma longa Linn. Several studies have reported that CURC has
numerous pharmacological activities, including antioxidant, anti-inflammatory, antitumor
and anti-bacterial effects [20]. CURC has strong antioxidant activity by exerting its effect
on reactive species, scavenging superoxide anion (O−), peroxynitrite (NOO), nitric oxide
(NO), peroxyl radicals (ROO), and hydroxyl (OH−) radicals, resulting in the upregulation
of antioxidant proteins [21]. Phenolic groups of CURC are responsible for its ability to
react with reactive species and might likely be one of the mechanisms via which CURC
administration protects cells from oxidative damage. In fact, CURC can indirectly induce
the expression of antioxidant proteins such as superoxide dismutase (SOD), catalase (CAT),
glutathione peroxidase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST),
and g-glutamyl cysteine ligase (gGCL) [21]. The hepatoprotective effects of CURC against
toxic chemical-induced liver injury have already been explored and have been attributed to
its intrinsic antioxidant properties [20,22–24]. Moreover, recently, S.S. Zhai and colleagues
have shown that dietary supplementation of CURC reversed serum biochemical changes
and ameliorated liver oxidative injury in White Pekin ducklings treated for three weeks
with OTA [25].
However, until now, the OTA response to differences in species was far from clear [26].
Various in vivo and in vitro studies have identified several diverse metabolites of OTA
in different species that could be the cause of slight differences from animals [27–29].
Therefore, the present study has been designed to investigate the efficacy of CURC on
OTA-induced hepatotoxicity.
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2. Materials and Methods
2.1. Chemicals
OTA and CURC were supplied by Sigma-Aldrich (Milan, Italy). SOD (Item No. 19160),
malondialdehyde (MDA) (Item No. MAK085), GPx (Item No. 38185), and CAT (Item No.
CAT100) assay kits were purchased from Sigma-Aldrich (Milan, Italy). Other chemicals
and reagents used in this work were purchased from Sigma-Aldrich (Milan, Italy). The
animal supplier was Charles River Laboratories (Milan, Italy).
2.2. Ethics Statement
The use and care of the animals in this work was approved by the Institutional
Animal Care and Ethics Committee (Approval Number: 487/2018-PR) and carried out in
accordance with the associated guidelines EU Directive 2010/63/EU.
2.3. Experimental Design and Sample Collection
Twenty-four male rats of the Sprague Dawley strain, 10 weeks old (250–270 g), used
in this study were randomly distributed into four experimental groups (6 rats for each
group) and were housed in cages under standard conditions (temperature 20 ± 2 ◦C and
12 h day/night cycles). The animals received a standard diet ad libitum. Animals were
treated daily for 14 days by gavage as follows: CONTROL group: 2 mL/kg b.w. of olive
oil; OTA group: 2 mL/kg b.w. of olive oil containing 0.5 mg/kg b.w. of ochratoxin A [30];
CURC group: 2 mL/kg b.w. of olive oil containing 100 mg/kg b.w. of curcumin [31];
OTA (2 mL/kg b.w. of olive oil containing 0.5 mg/kg b.w. of ochratoxin A) + CURC
(1 mL/kg b.w. of olive oil containing 100 mg/kg b.w. of curcumin). The use of olive oil has
served to improve the stability of CURC. The duration of the experiment (14 days) was
based on our previous work [30,32,33]. At the end of the experimental period, rats were
anesthetized with 2% isoflurane (Isotec 4, Palermo, Italy), and after complete sedation,
blood samples were collected from the aorta into nonheparinized bottles and processed
to aliquots for biochemical analysis. At the end of the treatment, rats were sacrificed by
cervical dislocation, and the kidney and liver were removed to measure the oxidative stress
markers and lipid peroxidation and were partially prepared for routine histopathology.
Kidney results are reported in our previous paper [34] where CURC has shown a good
recovery of kidney damage induced by OTA.
2.4. Determination of Serum Hepatic Function Biomarkers
The activities of the hepatic function biomarkers alanine aminotransferase (ALT),
aspartate aminotransferase (AST), and alkaline phosphatase (ALP) were measured after
14 days of treatment by an auto-chemistry analyzer (PKL PPC 125, Paramedical srl, Salerno,
Italy) following the instructions of the manufacturer of the commercial diagnostic kits,
expressing data in units per liter (U/L). Total protein concentrations of the serum were
colorimetrically determined [35].
2.5. Determination of Liver Antioxidant Enzyme Activities and Malondialdehyde
Liver samples from all groups were collected on day 14 of the treatment. One gram
of each liver sample was added to 9 mL of normal saline 0.9% and homogenized in ice,
using electrical tissue homogenizer (Tissue Lyser, Qiagen, Milano, Italy), and centrifuged
at 10,000× g for 15 min at +4 ◦C; resulting supernatants were stored at −80 ◦C. Then,
the supernatant was used to evaluate, by a spectrophotometer (Glomax Multi detection
system, Promega, Milano, Italy), the SOD, CAT, and GPx activities according to previous
studies [36–38]. These activities were expressed as units per milligram of protein (U/mg
of protein). Malondialdehyde (MDA), a marker of lipid peroxidation, was calculated
according to Ohkawa et al. [39]. The optical density (OD) of the supernatants was read by
a spectrophotometer at a wavelength of 532 nm and was expressed in nanomoles of MDA
per milligram of protein.
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2.6. Histopathological Studies
Livers of 24 male Sprague Dawley rats (6 rats per group), collected during necropsy,
were fixed in Bouin solution for 24 h and subsequently dehydrated in ascending ethyl
alcohol and then embedded in paraffin. Two serial sections at 3 µm were stained with
hematoxylin and eosin and with Masson’s trichrome stain and were examined and pho-
tographed with a light microscope (Nikon Eclipse E600) coupled with a microphotography
system (Nikon digital camera DMX1200). Hepatic lesions were scored by evaluating at
least 10 microscopic fields at 20× magnification and using already defined scoring systems.
Notably, inflammation was scored as follows: score 0, no inflammatory foci; score 1 (mild),
<2 foci per 20× field; score 2 (moderate), 2–4 foci per 20× field; score 3 (severe), >4 foci per
20× field. The extent of the steatosis was scored as follows: score 0, <5% of hepatocytes;
score 1 (mild), 5–33%; score 2 (moderate), >33–66%, score 3 (severe), >66% [40]. The extent
of the necrosis was scored as follows: score 0, 0% of hepatic tissue; score 1 (mild), <10%;
score 2 (moderate), >10–50%, score 3 (severe), >50% [41]. Furthermore, the presence or
absence of fibrosis, sinusoidal dilation, and central vein dilation was recorded for each
case [42].
2.7. Statistical Analysis
Statistical analysis of enzymatic activities was expressed as mean ± standard devi-
ation (SD). Analysis of variance (ANOVA) tests followed by a Tukey’s test were used to
analyze the differences (GraphPad Software 3.00, San Diego, CA, USA). Each animal group
consisted of 6 rats and the experiment was conducted in triplicate. Values of * p < 0.05 were
considered statistically significant.
Statistical analysis of the liver histology was performed using IBM SPSS Statistics
(Version 25) with a level of significance of 0.05. Each animal group consisted of 6 rats
and the experiment was conducted in triplicate. The differences in the distribution of the
histologic semiquantitative scores among groups were compared using the Kruskal-Wallis
H test and a post hoc multiple comparison using Dunn’s test. The difference in frequency
of fibrosis, sinusoidal dilation, and central vein dilation among groups was evaluated with
a two-tailed Fisher’s exact test.
3. Results
3.1. Effect of CURC on Liver Biochemical Analyses in Rats
The activities of the hepatic function biomarkers ALT, AST, and ALP and the total
protein in rats treated after 14 days of treatment are presented in Table 1. The oral admin-
istration of OTA caused a significant increase in ALT, AST, and ALP activities (increases
of −55.7%, −37.1%, and −71%, respectively) and caused a significant reduction in the
concentration of total protein (reduction of 53.1%) compared to the CONTROL group after
14 days of treatment. However, the cotreatment with CURC significantly reduced the
adverse effects of OTA at the end of treatment, significantly lowering ALT, AST, and ALP
activities by 30.7%, 19.8%, and 54.1%, respectively, and increasing the concentration of the
proteins in the serum by −31%.
3.2. Activity of Antioxidant Enzymes SOD, CAT, and GPx
The antioxidant markers SOD, CAT, and GPx in the livers of the rats in the different
experimental groups after 14 days of treatment are shown in Figure 1a–c. The activities
of SOD, CAT, and GPx were significantly decreased in the liver of OTA-treated rats in
comparison to the CONTROL group. In fact, SOD value was 7.51 ± 0.5 in CONTROL
group and 6.30 ± 0.3 in OTA group (* p < 0.05), CAT value was 2.66 ± 0.1 in CONTROL
group and 2.23 ± 0.2 in OTA group (* p < 0.05), and GPx value was 13.5 ± 1.2 in CONTROL
group and 5.1 ± 1.5 in OTA group (**** p < 0.0001). Cotreatment with CURC showed a
good recovery of SOD, CAT, and GPx activities compared to the OTA group. In fact, the
SOD value was 8.25 ± 0.4 in the OTA plus CURC group, compared to 6.30 ± 0.3 in the OTA
group (# p < 0.05). The CAT value was 2.95 ± 0.1 in the OTA plus CURC group, compared
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to 2.23 ± 0.2 in the OTA group (# p < 0.05). The GPx value was 10.2 ± 2.1 in the OTA plus
CURC group, compared to 5.1 ± 1.5 in the OTA group (#### p < 0.0001). When CURC was
used alone, no change in SOD, CAT, and GPx activities was observed when compared to
the CONTROL group. In fact, the SOD value was 8.1 ± 0.8 in the CURC group, compared
to 7.51 ± 0.5 in the CONTROL group. The CAT value was 2.53 ± 0.14 in the CURC group,
compared to 2.66 ± 0.1 in the CONTROL group. The GPx value was 15.4 ± 2.6 in the
CURC group, compared to 13.5 ± 1.2 in the CONTROL group.
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CAT activity; (c liver GPx ac ivity. Co trol group (C NTROL); curcumin group (CURC); ochra-
toxin A group (OTA); curcumin plus ochratoxin A group (CURC + OTA). Data are expressed as
mean ± standard deviation (SD) of n = 6 rats. OTA treatment significantly decreased SOD, CAT, and
GPx enzyme activities, while coadministration with CURC significantly restored this effect (* p < 0.05
and **** p < 0.0001 vs. CONTROL; # p < 0.05 and #### p < 0.0001 vs. OTA).
3.3. Lipid Peroxidation
MDA levels in the liver tissues were significantly increased in OTA when com-
pared to CONTROL group (0.38 ± 0.024 in CONTROL compared to 0.90 ± 0.031 in OTA
(**** p < 0.001)). Cotreatment with curcumin showed a significant decrease in MDA con-
centration compared to the OTA group. Indeed, the MDA value changed from 0.99 ± 0.031
(OTA) to 0.42 ± 0.015 (OTA+ CURC) (#### p < 0.001). When CURC was used alone, there
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was no change in MDA levels compared to the CONTROL group (0.35 ± 0.012 in CURC
compared to 0.38 ± 0.024 in CONTROL) (Figure 2).
Table 1. Serum biochemical parameters: alanine aminotransferase (ALT), aspartate aminotransferase
(AST), and alkaline phosphatase (ALP) activities expressed in units per liter (U/L) and total protein
expressed in grams per deciliter (g/dL) in the different groups of rats after 14 days of treatment.
Control group (CONTROL); curcumin group (CURC); ochratoxin A group (OTA); ochratoxin A plus
curcumin group (OTA + CURC). Data are expressed as mean ± standard deviation (SD) of n = 6 rats.
(* p < 0.05 and **** p < 0.0001 vs. CONTROL; # p < 0.05, ### p < 0.001, and #### p < 0.0001 vs. OTA).
Groups ALT (U/L) AST (U/L) ALP (U/L) TOTAL PROTEIN(g/dL)
CONTROL 45.33 ± 6.4 118.82 ± 1.45 25.60 ± 5.8 81.55 ± 3.49
CURC 40.11 ± 5.3 100.50 ± 6.2 21.50 ± 5.6 84.47 ± 1.35
OTA 102.21 ± 5.8 **** 188.91 ± 4.6 **** 88.32 ± 4.9 **** 53.25 ± 2.55 *
OTA + CURC 78.20 ± 4.7 #### 157.72 ± 6.1 ### 57.31 ± 5.2 ### 77.14 ± 2.36 #
3.4. Histopathological Examination
Rat livers from CONTROL and CURC-treated groups rarely showed mild, multifo-
cal, random lymphoplasmacytic inflammation, and mild to severe steatosis. No necrosis
was observed in the livers of rats in CONTROL and CURC-treated groups. No statistical
differences were observed between CONTROL and CURC treated groups regarding in-
flammation, steatosis, necrosis, and fibrosis. Central vein dilation was more frequent in the
CURC group compared to the CONTROL group. Differently, livers from the OTA-treated
group showed moderate to severe, multifocal, random lymphoplasmacytic inflammation,
moderate to severe steatosis, and moderate to severe necrosis. Portal spaces were often
multifocally expanded by moderate to severe fibrosis. OTA group showed a more severe
inflammation compared with CURC group (p < 0.05) and a more severe necrosis com-
pared with both CONTROL (p < 0.01) and CURC groups (p < 0.01). Fibrosis was more
frequently observed in the OTA group when compared with both CONTROL and CURC
groups (p < 0.05). Central vein dilation was observed more frequently in OTA-treated rats
compared with CONTROL (p < 0.05). No significant differences were observed in inflam-
mation, steatosis, necrosis, fibrosis, and central vein dilation comparing OTA + CURC
with CONTROL, CURC, and OTA groups. No significant differences in sinusoidal dilation
frequency were observed among groups (Figure 3A,B).
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Figure 3. (A) Rats, liver, hematoxylin and eosin (HE) and Masson’s trichrome (MTRC) stains,
40× magnification, scale bar = 100 µm. Control group (CONTROL); curcumin group (CURC); ochra-
toxin A group (OTA); ochratoxin A plus curcumin group (OTA + CURC). (A) Rats of the CONTROL
a d CURC groups showed numerous disseminate swollen hepat cytes with intracytoplasmic
optically empty vacuoles (steatosis, arrowheads) ith HE stain and a normal amount of interstitial
connective tissue (blue) with MTRC stain. OTA-treated rats showed periportal infiltration of lym-
phocytes (arrows) and n merous dissem na ed swolle hepatocytes with intracytoplasmic optically
empty vacuoles (steatosis, arrowheads). Rats of the OTA group also showed portal spaces severely
expanded by abundant fibrous connective tissue (blue) with MTRC stain. Rats of the OTA + CURC
group show d foc l periportal infiltration of lymphocytes (arrow) and umerous disseminated
swollen hepatocytes with intracytoplasmic optically empty vacuoles (steatosis, arrowheads) with
HE stain. Rats of the OTA + CURC group showed portal spaces moderately expanded by fibrous
connective tissue (blue) with MTRC stain. (B) Severity scores of inflammation, steatosis, and necrosis
for each group. Asterisks represent statistically significant differences between groups (* p < 0.05,
** p < 0.01).
4. Discussion
OTA is a widely spread worldwide mycotoxin and represents an emerging health
problem for both humans and animals, due to its deleterious effects and its high presence
in feed and food [43]. In consequence, the European Union (EU) and Joint Food and
Agriculture Organization (FAO)/World Health Organization (WHO) have evaluated the
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risk assessment of OTA and recommended regulatory levels to control or prevent OTA con-
tamination [44]. Therefore, OTA has received utmost special attention from professionals of
microbiology, toxicology, and food technology. Despite several in vivo and in vitro studies
published on the nephrotoxicity and hepatotoxicity of OTA, the exact mechanisms involved,
as well as the influence of oxidative stress on the deleterious effects of these mycotoxins,
are not yet clear [20,33,45–47]. Several antioxidant compounds have been studied for their
protective effects against OTA-induced organ toxicity [30,46,48]. However, there is no study
about the potential effects of CURC on OTA-induced hepatotoxicity in rats. The protective
effects of CURC on OTA-induced liver oxidative injury have been recently demonstrated
in ducks, where CURC was able to restore the liver CAT activity with good recovery of
the OTA-induced alteration in the composition of intestinal microbiota [25]. Therefore,
the present work has been conducted to investigate, for the first time, the possible hepato-
protective effects of CURC against OTA intoxication in rats. Although the liver is not the
main target organ for OTA, it remains one of the most sensitive organs to toxic exogenous
substances as hepatocytes are exposed to OTA, which must pass through the liver after
intestinal absorption [49]. Additionally, OTA was suggested to cause an imbalance between
oxidant/antioxidant parameters in both the kidney and liver of rats [50]. Considering that
some polyphenolic compounds with established antioxidant properties may be used in the
prevention of the induced hepatotoxicity [51], the current study focused on the antioxidant
effects of CURC in reducing OTA oxidative stress in the liver of rats. Considering the
chemical properties of CURC such as low water solubility, poor stability in body fluids,
high rate of metabolism, rapid clearance, reduced absorption in the gastrointestinal tract,
and limited bioavailability [52,53], numerous innovative approaches have been employed
in recent years to increase its solubility and bioavailability [54,55]. To increase the stability
and intestinal absorption of CURC, olive oil was used as a solvent, according to other data
in the literature [56]. The liver is constantly negatively affected by various xenobiotics and
free radicals, as it is the organ in charge of biotransformation processes. In fact, several
studies reported CURC as a scavenger for the oxygen-derived free radicals [34,57]. In this
study, we analyzed the main serum biomarkers essential for the determination of liver
injury [58,59], and we found, in rats treated with OTA for 14 days, a significant increase
in serum aminotransferases (ALT and AST) and ALP that suggests damage to the liver
cells. Moreover, the total protein concentrations were significantly reduced, and this may
have been due to loss of hepatocytes as a result of OTA damage, leading to disturbances
of protein biosynthesis. In contrast, cotreatment with CURC significantly reduced the
serum levels of ALT, AST, and ALP, evidencing the protective effects of CURC. CURC has
been shown to prevent the destruction of liver enzymes in the serum and thus protect the
hepatocytes from OTA-induced hepatotoxicity. The significant reduction in the activities
of these enzymes in the curcumin-treated group suggests a chelating effect of curcumin.
A significant increase in the serum total protein concentration was observed in the group
treated with CURC administrated in association with OTA when compared to the OTA
group. This study, according to the studies of Emad et al. [59] and Omowumi et al. [60],
allows us to hypothesize that CURC increases protein synthesis in liver cells damaged
by OTA for a regenerative effect on liver tissue. Mycotoxins cause the release of free
radicals, induce lipid peroxidation, and change the antioxidant status of cells, leading to
oxidative stress [34,61]. Therefore, in this study, we have evaluated the activity of the main
antioxidant enzymes, namely CAT, SOD, and GPx, which play a key role in protecting
against oxidative stress induced by reactive oxygen species [62]. Here, the activities of CAT,
SOD, and GPx were significantly reduced in the liver of OTA-treated rats; according to data
in the literature [63], mainly the activity of GPx and selenoenzyme catalyzes the reduction
of hydrogen peroxide to water utilizing glutathione (GSH), which can be attributed to the
decrease in selenium levels due to OTA interference with its essential uptake. Therefore,
according to the studies of Palabiyik et al. [50] and Domijan et al. [64], we hypothesize that
the toxic action of OTA is partly related to the reduction in the antioxidant enzyme activities
and partly to the increase in free radical generation. In fact, the high generation of free
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radicals causes an imbalance between oxidant and antioxidant systems inducing oxidative
stress. In accordance with the data in the literature [19,65] OTA causes the overproduction
of free radicals determining damage to cell constituents, such as membrane lipids. In the
current study, after 14 days of treatment, an increase in the MDA level in the liver tissue
was observed in the OTA-treated rats. The increase in MDA levels can be considered as a
marker of tissue injury induced by OTA. The literature reports that the beneficial effects of
CURC are linked to its antioxidant properties, which play a key role in hepatoprotective
mechanisms, through the elimination of free radicals and strengthening of the activity of
the natural antioxidant defense system [66–70]. In this study, the treatment with CURC,
used alone or in association with OTA, revealed a significant reversion of the activities of
CAT, SOD, and GPx and MDA levels, inhibiting effects of oxidative stress induced by OTA.
The antistress activity of CURC may be partly due to its antioxidant effect, which
leads to an elimination of free radicals and a decline in the biosynthesis of mycotoxins [71],
demonstrating potent antifungal and antimycotoxin activities on A. ochraceous and P.
verrucosum [72].
These findings were supported by liver histopathological analysis, where the mul-
tifocal lymphoplasmacellular hepatitis, periportal fibrosis, and hepatocellular necrosis
observed in the OTA group were consistent with the lesions already reported in the livers
of rats treated with OTA [40]. Central vein dilation in the OTA group was consistent with
the data obtained by previous studies [42] and might be due to developing hypertension
secondary to the OTA-dependent renal damage [45]. The less severe inflammation, steato-
sis, and necrosis scores reported in the rats of the OTA + CURC group compared to the
OTA group are consistent with the molecular results.
5. Conclusions
Our results confirmed that oxidative stress is involved in the OTA hepatotoxicity
mechanism and exposure to OTA induces negative effects and profound changes in liver
functions. CURC treatment was responsible for a restoration in liver function, biochemical
and antioxidant enzyme activities, and MDA levels. Therefore, the use of CURC, due to
its antioxidant activity, could overcome oxidative stress and decrease the biosynthesis of
mycotoxins in food sources, while protecting human and animal health.
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17. Kőszegi, T.; Poór, M. Ochratoxin A: Molecular Interactions, Mechanisms of Toxicity and Prevention at the Molecular Level. Toxins
2016, 8, 111. [CrossRef]
18. Ramyaa, P.; Krishnaswamy, R.; Padma, V.V. Quercetin modulates OTA-induced oxidative stress and redox signalling in HepG2
cells—Up regulation of Nrf2 expression and down regulation of NF-κB and COX-2. Biochim. Biophys. Acta-Gen. Subj. 2014, 1840,
681–692. [CrossRef]
19. Costa, J.G.; Saraiva, N.; Guerreiro, P.S.; Louro, H.; Silva, M.J.; Miranda, J.P.; Castro, M.; Batinic-Haberle, I.; Fernandes, A.S.;
Oliveira, N.G. Ochratoxin A-induced cytotoxicity, genotoxicity and reactive oxygen species in kidney cells: An integrative
approach of complementary endpoints. Food Chem. Toxicol. 2016, 87, 65–76. [CrossRef]
20. Sankar, P.; Gopal Telang, A.; Kalaivanan, R.; Karunakaran, V.; Manikam, K.; Sarkar, S.N. Effects of nanoparticle-encapsulated
curcumin on arsenic-induced liver toxicity in rats. Environ. Toxicol. 2015, 30, 628–637. [CrossRef]
21. Trujillo, J.; Chirino, Y.I.; Molina-Jijón, E.; Andérica-Romero, A.C.; Tapia, E.; Pedraza-Chaverrí, J. Renoprotective effect of the
antioxidant curcumin: Recent findings. Redox Biol. 2013, 1, 448–456. [CrossRef]
22. Farombi, E.O.; Shrotriya, S.; Na, H.-K.; Kim, S.-H.; Surh, Y.-J. Curcumin attenuates dimethylnitrosamine-induced liver injury in
rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem. Toxicol. 2008, 46, 1279–1287. [CrossRef] [PubMed]
23. Wang, M.-E.; Chen, Y.-C.; Chen, I.-S.; Hsieh, S.-C.; Chen, S.-S.; Chiu, C.-H. Curcumin protects against thioacetamide-induced
hepatic fibrosis by attenuating the inflammatory response and inducing apoptosis of damaged hepatocytes. J. Nutr. Biochem.
2012, 23, 1352–1366. [CrossRef] [PubMed]
24. Messarah, M.; Amamra, W.; Boumendjel, A.; Barkat, L.; Bouasla, I.; Abdennour, C.; Boulakoud, M.S.; Feki, A.E. Ameliorating
effects of curcumin and vitamin E on diazinon-induced oxidative damage in rat liver and erythrocytes. Toxicol. Ind. Health 2013,
29, 77–88. [CrossRef] [PubMed]
25. Zhai, S.S.; Ruan, D.; Zhu, Y.; Li, M.C.; Ye, H.; Wang, W.C.; Yang, L. Protective effect of curcumin on ochratoxin A-induced liver
oxidative injury in duck is mediated by modulating lipid metabolism and the intestinal microbiota. Poult. Sci. 2020, 99, 1124–1134.
[CrossRef] [PubMed]
26. Xiaozhe, Q.; Tao, Y.; Liye, Z.; Jing, G.; Xiaoyun, H.; Kunlun, H.; Yunbo, L.; Wentao, X. Ochratoxin A induces rat renal
carcinogenicity with limited induction of oxidative stress responses. Toxicol. Appl. Pharmacol. 2014, 280, 543–549. [CrossRef]
27. Zhu, L.; Yu, T.; Qi, X.; Gao, J.; Huang, K.; He, X.; Luo, H.; Xu, W. Limited link between oxidative stress and ochratoxin A—Induced
renal injury in an acute toxicity rat model. Toxins 2016, 8, 373. [CrossRef]
28. Pinelli, E.; El Adlouni, C.; Pipy, B.; Quartulli, F.; Pfohl-Leszkowicz, A. Roles of cyclooxygenase and lipoxygenases in ochratoxin A
genotoxicity in human epithelial lung cells. Environ. Toxicol. Pharmacol. 1999, 7, 95–107. [CrossRef]
Antioxidants 2021, 10, 125 11 of 12
29. Hohler, D.; Sudekum, K.H.; Wolffram, S.; Frohlich, A.A.; Marquardt, R.R. Metabolism and excretion of ochratoxin A fed to sheep.
J. Anim. Sci. 1999, 77, 1217–1223. [CrossRef]
30. Damiano, S.; Navas, L.; Lombari, P.; Montagnaro, S.; Forte, I.M.; Giordano, A.; Florio, S.; Ciarcia, R. Effects of δ-tocotrienol on
ochratoxin A-induced nephrotoxicity in rats. J. Cell. Physiol. 2018, 233, 8731–8739. [CrossRef]
31. Avci, H.; Epikmen, E.T.; Ipek, E.; Tunca, R.; Birincioglu, S.S.; Akşit, H.; Sekkin, S.; Akkoç, A.N.; Boyacioglu, M. Protective effects
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